首页> 外国专利> Sulphanilamide derivs - by catalytic hydrogenation of corresp alkenyl derivs-hypoglycaemic activity

Sulphanilamide derivs - by catalytic hydrogenation of corresp alkenyl derivs-hypoglycaemic activity

机译:磺胺甲酰胺衍生物-通过相应的烯基衍生物的催化氢化降低血糖活性

摘要

New cpds. of formula (I): (where R1 = alkyl (3-5C) or cycloalkyl(5-7C); R2 = methyl or ethyl; or acid -addn. salts of (I) are prepd. by reduction of a cpd. (II): 1: - NH2 is - X and R1 is R1' where R1' = alkenyl (3-5C) or cycloalkenyl(5-7C); X = amino or a residue which can be hydrolyses, reduced etc. to a free amino group. reduction pref. using H2 in the presence of a catalyst (I) have hypoglycaemic activity, esp. 1-sulphanilyl-2-imino-3-butyl-5-ethyl-imidazolidine shows this activity upon peroral or parenteral administration and may be used in the treatment of diabetes.
机译:新的cpds。式(I)的通式:(其中R 1 =烷基(3-5C)或环烷基(5-7C); R 2 =甲基或乙基;或酸加成(I)的盐通过将cpd还原而制备。 II):1:-NH 2是-X,R 1是R 1',其中R 1'=烯基(3-5C)或环烯基(5-7C); X =氨基或可水解,还原等成游离基的残基在催化剂存在下使用H2还原氨基基团(I)具有降血糖活性,尤其是1-磺基甲磺酰基-2-亚氨基-3-丁基-5-乙基-咪唑烷在口服或肠胃外给药时均具有这种降血糖活性,可能用于治疗糖尿病。

著录项

  • 公开/公告号CH518284A

    专利类型

  • 公开/公告日1972-01-31

    原文格式PDF

  • 申请/专利权人 CIBA-GEIGY AG;

    申请/专利号CH19690002947

  • 发明设计人 DIETRICHHENRIDR.;

    申请日1969-02-28

  • 分类号C07D49/30;

  • 国家 CH

  • 入库时间 2022-08-23 08:40:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号